How can the industry empower MSLs as they do sales reps?

The Sunshine Rule swept away the clouds that cast shade over the pharmaceutical industry’s interactions with its customers, but what has been its impact five years on?

Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.

Are public-private partnerships set to be drivers of innovation across the pharmaceutical industry? Read to find out more.

Non-adherence to medication can be caused by a range of factors, including unconscious biases. How can pharma rework current models to ensure they are connecting with patients?

Read the article to find out what action the pharma industry has taken to help Ukraine during the conflict.

Antimicrobial resistance poses a significant threat to human health worldwide, with inconceivable consequences. Is pharma doing enough?

Claus Zieler, President of Established Markets at Astellas, speaks about the role leaders play in cultivating an enticing company culture